AU2001292802A1 - Genetic markers for tumors - Google Patents

Genetic markers for tumors

Info

Publication number
AU2001292802A1
AU2001292802A1 AU2001292802A AU9280201A AU2001292802A1 AU 2001292802 A1 AU2001292802 A1 AU 2001292802A1 AU 2001292802 A AU2001292802 A AU 2001292802A AU 9280201 A AU9280201 A AU 9280201A AU 2001292802 A1 AU2001292802 A1 AU 2001292802A1
Authority
AU
Australia
Prior art keywords
tumors
genetic markers
markers
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292802A
Inventor
Michael Angelo
Todd B. Golub
Sridhar Ramaswamy
Pablo Tamayo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Whitehead Institute for Biomedical Research
Original Assignee
Dana Farber Cancer Institute Inc
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc, Whitehead Institute for Biomedical Research filed Critical Dana Farber Cancer Institute Inc
Publication of AU2001292802A1 publication Critical patent/AU2001292802A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
AU2001292802A 2000-09-19 2001-09-19 Genetic markers for tumors Abandoned AU2001292802A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23353400P 2000-09-19 2000-09-19
US60/233,534 2000-09-19
US27874901P 2001-03-26 2001-03-26
US60/278,749 2001-03-26
PCT/US2001/029287 WO2002024956A2 (en) 2000-09-19 2001-09-19 Genetic markers for tumors

Publications (1)

Publication Number Publication Date
AU2001292802A1 true AU2001292802A1 (en) 2002-04-02

Family

ID=26926991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292802A Abandoned AU2001292802A1 (en) 2000-09-19 2001-09-19 Genetic markers for tumors

Country Status (5)

Country Link
US (1) US7105293B2 (en)
EP (1) EP1339872A2 (en)
JP (1) JP2004509629A (en)
AU (1) AU2001292802A1 (en)
WO (1) WO2002024956A2 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1307557A2 (en) 2000-08-02 2003-05-07 The Johns Hopkins University Endothelial cell expression patterns
EP1425413A2 (en) * 2001-01-23 2004-06-09 Irm, Llc Genes overexpressed in prostate disorders as diagnostic and therapeutic targets
CA2450379A1 (en) * 2001-06-10 2002-12-19 Irm Llc Molecular signatures of commonly fatal carcinomas
EP1308522A1 (en) * 2001-11-05 2003-05-07 Haferlach, Torsten, PD Dr. Dr. Novel genetic markers for leukemias
AU2002351828A1 (en) * 2001-11-05 2003-05-19 Deutsches Krebsforschungszentrum Novel genetic markers for leukemias
ATE364690T1 (en) 2001-11-09 2007-07-15 Proteologics Inc POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS
US7348142B2 (en) * 2002-03-29 2008-03-25 Veridex, Lcc Cancer diagnostic panel
ATE519862T1 (en) * 2002-08-20 2011-08-15 Millennium Pharm Inc COMPOSITIONS, KITS AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CERVICAL CANCER
US9233120B2 (en) * 2002-11-15 2016-01-12 Jyant Technologies Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
WO2004045526A2 (en) * 2002-11-15 2004-06-03 Morehouse School Of Medicine Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
WO2005007892A1 (en) * 2003-07-03 2005-01-27 Gentron, Llc Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples
US20110152115A1 (en) 2003-09-03 2011-06-23 The United States of America, as represented by the Secretary, Department of Health and Methods for identifying, diagnosing, and predicting survival of lymphomas
US8131475B2 (en) 2003-09-03 2012-03-06 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods for identifying, diagnosing, and predicting survival of lymphomas
EP1664762A4 (en) * 2003-09-03 2008-08-13 Us Gov Health & Human Serv Methods for identifying, diagnosing, and predicting survival of lymphomas
WO2005042760A2 (en) 2003-09-29 2005-05-12 Pathwork Informatics, Inc. Systems and methods for detecting biological features
US8321137B2 (en) 2003-09-29 2012-11-27 Pathwork Diagnostics, Inc. Knowledge-based storage of diagnostic models
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
KR20070057761A (en) 2004-06-04 2007-06-07 아비아라디엑스, 인코포레이티드 Identification of tumors
US20120258442A1 (en) 2011-04-09 2012-10-11 bio Theranostics, Inc. Determining tumor origin
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
JP2006141297A (en) * 2004-11-19 2006-06-08 Eiken Chem Co Ltd Marker for detecting vascularization
US20070118295A1 (en) * 2005-03-02 2007-05-24 Al-Murrani Samer Waleed Khedhe Methods and Systems for Designing Animal Food Compositions
CN101297045A (en) 2005-06-03 2008-10-29 阿威亚拉德克斯股份有限公司 Identification of tumors and tissues
JP2009515141A (en) * 2005-07-21 2009-04-09 ウェイン ステート ユニバーシティー Asbestos exposure, pleural mesothelioma, and serum osteopontin levels
US20070134687A1 (en) * 2005-09-12 2007-06-14 Aurelium Biopharma Inc. Focused microarray and methods of diagnosing cancer
ATE545708T1 (en) * 2005-11-14 2012-03-15 Univ Laval CANCER ANTIGEN MAGE-A9 AND USES THEREOF
NZ593229A (en) 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (gadd45b) for colorectal cancer prognosis
KR100835296B1 (en) 2006-11-23 2008-06-09 한국생명공학연구원 Methods of Selecting Gene Set Predicting Cancer Phenotype
US20110195064A1 (en) * 2008-06-06 2011-08-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Survival predictor for diffuse large b cell lymphoma
GB2467691A (en) * 2008-09-05 2010-08-11 Aueon Inc Methods for stratifying and annotating cancer drug treatment options
NZ596054A (en) 2009-05-01 2013-07-26 Genomic Health Inc Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
US20130058863A1 (en) * 2010-02-04 2013-03-07 Jake Yue Chen 4-Protein Biomarker Panel for the Diagnosis of Lymphoma from Biospecimen
RU2565550C2 (en) 2010-09-24 2015-10-20 Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити Direct capture, amplification and sequencing of target dna using immobilised primers
NZ589251A (en) * 2010-11-12 2014-07-25 Pacific Edge Ltd Novel marker for detection of bladder cancer
EP2726869B1 (en) 2011-06-29 2017-08-09 Duke University Somatic mutations in atrx in brain cancer
EP3594359B1 (en) 2013-11-06 2022-05-18 The United States of America, as represented by the Secretary, Department of Health and Human Services Method for subtyping lymphoma types by means of expression profiling
CN106191215B (en) * 2015-04-29 2020-03-24 中国科学院上海生命科学研究院 Screening and application of protein molecular marker Dkk-3 related to muscular atrophy
US20200239937A1 (en) * 2017-02-23 2020-07-30 The Council Of The Queensland Institute Of Medical Research Biomarkers for diagnosing conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053319A2 (en) 1997-05-21 1998-11-26 The Johns Hopkins University Gene expression profiles in normal and cancer cells
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1208191A4 (en) 1999-08-13 2003-12-10 Human Genome Sciences Inc 13 human colon and colon cancer associated proteins
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
US20040033502A1 (en) * 2001-03-28 2004-02-19 Amanda Williams Gene expression profiles in esophageal tissue

Also Published As

Publication number Publication date
WO2002024956A2 (en) 2002-03-28
WO2002024956A8 (en) 2003-03-06
EP1339872A2 (en) 2003-09-03
JP2004509629A (en) 2004-04-02
US7105293B2 (en) 2006-09-12
WO2002024956A3 (en) 2003-06-26
US20020110820A1 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
AU2001292802A1 (en) Genetic markers for tumors
AU2002351828A1 (en) Novel genetic markers for leukemias
AU2002361908A1 (en) Methods for identifying marker genes for cancer
AU2001233626A1 (en) Marker
AU2001235860A1 (en) Data distribution
AU2002217904A1 (en) Methods for efficiently minig broad data sets for biological markers
AU2002216774A1 (en) Eas marker
AU4430701A (en) Compounds for targeting
AU2001270082A1 (en) Gene markers for lung cancer
AU2001277194A1 (en) Transgenic identification markers
AU2001282149A1 (en) Improved marker
AU2001220281A1 (en) Rollerboard for road-skiing
AUPQ901700A0 (en) Molecular markers
AU2001295777A1 (en) Target
AU2001264247A1 (en) GASC1 gene
AU2001240103A1 (en) Reproduction-specific genes
AU2001277857A1 (en) Tumor necrosis factor-gamma
AUPQ749100A0 (en) New epilespy gene
AU2001285743A1 (en) Adipose-related gene
AU2001284265A1 (en) Genetic study
AU2001275072A1 (en) Molecular marker for mitosis
AU2001289297A1 (en) Data distribution
AU2001255129A1 (en) Molecular markers
AU2002228190A1 (en) Marker for roscovitine
AU6167200A (en) Selectable marker gene